FTH$8.72-3.54%
Faeth Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap & EV:$225.36M /
Float & O/S:Pro
Est. Net Cash/Sh:
Inst Own:Pro
DilutionScan read 51 of Faeth Therapeutics, Inc.'s SEC filings and found 3 warrant series, 2 convertibles, 2 ATM programs, 2 shelf registrations and 1 completed offering on file for FTH. The latest dilution event on file is ATM sales on Nov 3, 2026. Analysis updated Nov 18, 2026.